Cannabinoid News and Research

Latest Cannabinoid News and Research

New insight into fast-growing retail and medicinal cannabis industry

Edison Group, the leading investment and research advisory company, has published its sector report analyzing the growing retail and medicinal cannabis industry.

3 May 2019

Cannabis, Alcohol and the Epigenome

With the legalization of cannabis in many US states, we explore the epigenetic effects of cannabis, cannabis-derived products, and alcohol.

29 Apr 2019

CBD could help slip medications into the brain

Cannabidiol, a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy.

17 Apr 2019

Don't Believe the Hemp: UHPLC Analysis of Hemp Seed Oils

Despite the popularity of hemp seed oil products, there are currently no standardized analysis techniques. To this end, researchers have been exploring the use of HPLC-MS for cannabinoid profiling of hemp.

10 Apr 2019

Online cannabis oils contain dangerous amounts of psychoactive THC

Scientists have published a review in the BMJ which calls for more research and regulations surrounding CBD oils offered by online sellers, after it was found that most contain the psychoactive ingredient THC.

8 Apr 2019

Clinical review offers advice for doctors in prescribing cannabinoids for certain conditions

A clinical review, published today for the BMJ, provides new interim advice for doctors and clinicians in prescribing cannabis-based products and cannabinoids to treat certain conditions.

8 Apr 2019

Scientists develop new accurate computational method to enhance drug target stability

Scientists from the Moscow Institute of Physics and Technology, the Skolkovo Institute of Science and Technology, and the University of Southern California have developed a new computational method for the design of thermally stable G protein-coupled receptors that are of great help in creating new drugs.

30 Mar 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

Sativa Investments completes 1000th cannabinoid and terpenes test at PhytoVista Laboratories

Sativa Investments PLC, the UK’s first medicinal cannabis investment vehicle, has completed its 1000th cannabinoid and terpenes test at its on-site testing facility, PhytoVista Laboratories (“PhytoVista”).

25 Mar 2019

Acute doses of synthetic cannabinoid can impair critical thinking and memory

A new study shows that inhaled doses of as little as 2 mg of the synthetic cannabinoid JWH-018 can significantly impair critical thinking and memory, slow reaction times, and increase confusion and dissociation.

19 Mar 2019

Structure of human type 2 cannabinoid receptor revealed

A Chinese research team joined forces with Russian and U.S. biologists to obtain the crystal structure of the human type 2 cannabinoid receptor.

28 Feb 2019

Researchers solve major gap in scientific literature with mobile software technology

Researchers at the University of New Mexico recently solved a major gap in scientific literature by using mobile software technology to measure the real-time effects of actual cannabis-based products used by millions of people every day.

27 Feb 2019

Keynote speakers announced for CBD Expo MIDWEST

CBD Expo Tour 2019, produced by MACE Media Group, one of the nation’s largest diversified media and information companies in the cannabis space and publisher of Terpenes and Testing Magazine, announced Celeste Miranda and Adam Dr. Adam Abodeely, MD, MBA, FACS, FASCRS will be the keynote speakers for CBD Expo MIDWEST in Indianapolis, Indiana to take place on March 15-16, 2019.

From CBD Expo Midwest 13 Feb 2019

Cannabinoid receptor type 1 appears to be potential target to treat Down syndrome

A study by the Neuropharmacology Laboratory-NeuroPhar of the Department of Experimental and Health Sciences at UPF reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome.

7 Feb 2019

Cannabinoid compounds may reduce viability of colon cancer cells

Medical marijuana has gained attention in recent years for its potential to relieve pain and short-term anxiety and depression. Now, Penn State College of Medicine researchers say some cannabinoid compounds may actually inhibit the growth of colon cancer cells in the lab.

6 Feb 2019

Are Electronic Cigarettes Facilitating Illicit Drug Use?

In this interview, Dr. Michelle Peace provides an introduction to her research into the use of e-cigarettes for the inhalation of illicit drugs.

From Pittcon 5 Feb 2019

New sessions at Pittcon 2019

Pittcon 2019 will be held March 17-21, 2019 in Philadelphia PA at the Pennsylvania Convention Center. A number of new events and sessions will be held.

From Pittcon 23 Jan 2019

Low-level cannabis use can change the adolescent brain

Teenagers who report using recreational marijuana just once or twice display increased volume of numerous brain regions, according to a study of 14-year-olds from Ireland, England, France, and Germany.

From Society for Neuroscience 16 Jan 2019

Therapeutic implications of caffeine in neuropsychiatric disorders

An important new article reviews recently discovered properties of adenosine A2A receptor-dopamine D2 receptor and adenosine A1 receptor-dopamine D1 receptor heteromers--both of which are main targets for caffeine--and discusses the therapeutic implications of these findings.

7 Jan 2019

Experts address sleep disorders following traumatic brain injury

Disorders of sleep are some of the most common problems experienced by patients after traumatic brain injury. It is important to recognize and treat these problems early to allow for optimal cognitive recovery, but because they are so common, the importance of treating them is often underestimated.

10 Dec 2018